(#6 of 12): As a former user, what impact did implementing RIVA™ have on your pharmacy? | George Smith | ARxIUM

#6: AS A FORMER USER, WHAT IMPACT DID IMPLEMENTING RIVA™ HAVE ON YOUR PHARMACY? | GEORGE SMITH | ARxIUM

Watch the Full Series

#1: WHY DO YOU ADVOCATE AUTOMATING THE STERILE COMPOUNDING PROCESS VS. THE MORE WIDELY USED MANUAL PROCESS? | GEORGE SMITH | ARXIUM

#2: WHAT ARE SOME OF THE BIGGEST MISPERCEPTIONS ABOUT AUTOMATED IV COMPOUNDING SOLUTIONS? | GEORGE SMITH | ARxIUM

#3: IN YOUR EXPERIENCE, WHAT KINDS OF HOSPITALS HAVE BEEN SUCCESSFUL IN AUTOMATING THE STERILE IV COMPOUNDING PROCESS? | GEORGE SMITH | ARxIUM

#4: WHAT STEPS CAN YOU RECOMMEND TO HOSPITALS THAT HAVE DECIDED TO AUTOMATE THAT WILL HELP ENSURE A SMOOTH IMPLEMENTATION? | GEORGE SMITH | ARxIUM

#5: WHAT IS YOUR PERSPECTIVE ON THE VALUE OF AUTOMATION IN TODAY’S EVER-CHANGING REGULATORY ENVIRONMENT? | GEORGE SMITH | ARxIUM

#6: AS A FORMER USER, WHAT IMPACT DID IMPLEMENTING RIVA™ HAVE ON YOUR PHARMACY? | GEORGE SMITH | ARxIUM

#7: AREN’T ALL AVAILABLE AUTOMATED SOLUTIONS “GOOD ENOUGH” WHEN COMPARING THEM TO MANUAL PROCESSES? | GEORGE BOYCE | ARxIUM

#8: WHAT ABOUT THE RIVA™ DESIGN MAKES IT THE INDUSTRY STANDARD FOR SAFETY AND STERILITY? | CRAIG BOYCE | ARxIUM

#9: WHAT MAKES RIVA™ THE RIGHT AUTOMATED SOLUTION FOR 503B OR CENTRAL PROCESSING ENVIRONMENTS? | CRAIG BOYCE | ARxIUM

#10: WHAT IS IT ABOUT RIVA™ THAT HELPS PROMOTE COMPLIANCE WITH EVOLVING REGULATIONS AND GUIDANCE? | CRAIG BOYCE | ARxIUM

#11: WHAT KEY FACTORS HAVE LED TO RIVA™ ACHIEVING MORE THAN 10 MILLION DOSES PREPARED ACCURATELY AND SAFELY? | CRAIG BOYCE | ARxIUM

#12: AS A FORMER USER, WHAT IMPACT DID IMPLEMENTING RIVA™ HAVE ON YOUR PHARMACY? | CRAIG BOYCE | ARxIUM